Skip to content
ITIF Logo
ITIF Search

Science and R&D

As nations engage in a race for global advantage in innovation, ITIF champions a new policy paradigm that ensures businesses and national economies can compete successfully by spurring public and private investment in foundational areas such as research, skills, and 21st century infrastructure. In the area of science and R&D policy, ITIF promotes public and private investment in research and development through public funding for research at national laboratories and universities, tax incentives to encourage business R&D, and policies to spur technology transfer from lab to market.

Robert D. Atkinson
Robert D. Atkinson

Senior Fellow

Information Technology and Innovation Foundation

Read Bio
Stephen Ezell
Stephen Ezell

Executive Vice President, Global Innovation Policy

Information Technology and Innovation Foundation

Read Bio
L. Val Giddings
L. Val Giddings

Senior Fellow

Information Technology and Innovation Foundation

Read Bio
Sejin Kim
Sejin Kim

Associate Director, Center for Korean Innovation and Competitiveness

Information Technology and Innovation Foundation

Read Bio
Trelysa Long
Trelysa Long

Policy Analyst

Information Technology and Innovation Foundation

Read Bio
Meghan Ostertag
Meghan Ostertag

Policy Analyst

Information Technology and Innovation Foundation

Read Bio
Lawrence Zhang
Lawrence Zhang

Head of Policy, Centre for Canadian Innovation and Competitiveness

Information Technology and Innovation Foundation

Read Bio

Featured

China Is Rapidly Becoming a Leading Innovator in Advanced Industries

China Is Rapidly Becoming a Leading Innovator in Advanced Industries

There may be no more important question for the West’s competitive position in advanced industries than whether China is becoming a rival innovator. While the evidence suggests it hasn’t yet taken the overall lead, it has pulled ahead in certain areas, and in many others Chinese firms will likely equal or surpass Western firms within a decade or so.

Why Congress Should Restore Full Expensing for Investments in Equipment and Research and Development

Why Congress Should Restore Full Expensing for Investments in Equipment and Research and Development

The tax law allowing firms to fully expense their research and development (R&D) costs expired at the end of 2021, and full expensing of equipment costs will begin phasing out in 2023. This decreases firms’ incentive to invest in these key drivers of economic growth and competitiveness. Congress should restore and make permanent full expensing for these investments.

More Publications and Events

August 20, 2026|Events

Can the United States Retain Its Scientific Talent?

Join ITIF for an expert panel discussion on the growing challenge of retaining scientific talent in the United States. Panelists will examine whether recent departures signal the beginning of a broader trend, what factors are driving scientists to leave, and which policies can help the United States retain top researchers and bolster innovation and economic competitiveness.

July 21, 2026|Testimonies & Filings

Testimony to the US Senate Subcommittee on Science, Manufacturing, and Competitiveness on “Measuring What Matters: Science, Standards, and Strategic Competition”

The utopian vision of globally integrated, democratic, free-market economies working together in harmony has not materialized. Meanwhile, the belief that China could not innovate—and that America would continue to lead in advanced technologies—also has proven to be false. These new realities require bold reforms in the U.S. research system.

July 20, 2026|Blogs

America Needs Both Small and Large Firms

Both small and large firms are essential to America’s innovation system because they specialize in different forms of innovation. Congress should double the regular R&D tax credit to 40 percent and reduce the red tape associated with claiming it.

July 20, 2026|Reports & Briefings

Commercializing Canadian Health Research: The Case for Targeting Grants and Increasing Overall Investment

Canada should significantly expand commercialization-focused grant programs through the Canadian Institutes of Health Research (CIHR) and increase Canada’s overall health science research investments to a scale commensurate with global competition.

July 20, 2026|Reports & Briefings

Paying for Outcomes: Tying University Funding to Commercial Results

Canada funds university research but gives universities too little reason to turn that into Canadian firms, patents, and industrial capacity. To better align their incentives with national goals, funding should flow in part on standardized commercialization outcomes, with universities left to decide how to deliver them.

July 13, 2026|Testimonies & Filings

Comments to OMB Regarding Its Proposed Rule to Revise the Guidance for Federal Financial Assistance

OMB’s proposed rule to increase the productivity and success of the U.S. scientific research establishment is commendable. But the rule in its totality would introduce dangerous and counterproductive revisions to the Uniform Guidance that would drastically reshape the American scientific enterprise for the worse and impose severe and long-lasting economic damage.

June 29, 2026|Blogs

Fact of the Week: 13 Percent of NIH Researchers Reported That Their Labs Lost Researchers to Other Countries Due to Funding Changes

In a survey of 1,000 U.S. researchers supported by the National Institutes of Health (NIH), 13 percent said that their labs had lost researchers to other countries as a result of NIH funding changes, while 14 percent reported that immigration policies forced scientists, students, and postdocs to turn down offers to work in NIH-supported labs.

June 17, 2026|Reports & Briefings

Mobilizing for Techno-Economic War, Part 5: Transforming STEM Research Policy

Increased federal funding for STEM research is necessary but not sufficient for America to avoid losing to China. It’s also time for a new model for federal research funding that focuses on the technology needs of national power industries and directly benefits firms in the United States.

June 16, 2026|Blogs

Canada’s Research Budget Does Not Match Its Innovation Strategy

Canada says it wants to be a technology and innovation economy, but its research budget still treats balance across disciplines as the priority. If innovation is the actual goal, the Carney government should shift funding from social sciences and humanities toward NSERC and CIHR.

May 6, 2026|Blogs

China Overtakes the United States in R&D Investment

China has overtaken the United States in R&D investment for the first time amid slowing U.S. R&D growth. Without stronger policy action, America risks falling further behind.

Back to Top